Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Bobby Gaspar
CEO | Chief Executive Officer | 60 | 01/01/15 |
Frank Thomas
PSD | President | 54 | 01/01/18 |
Leslie Meltzer
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Nicoletta Loggia
CTO | Chief Tech/Sci/R&D Officer | - | 09/09/21 |
Fulvio Mavilio
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Renee T. Leck
IRC | Investor Relations Contact | - | - |
Christopher York
SEC | Corporate Secretary | - | - |
Braden Parker
PRN | Corporate Officer/Principal | - | - |
John Cerio
HRO | Human Resources Officer | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Abdul Mullick
BRD | Director/Board Member | - | 24/01 |
Yasuo Fujii
BRD | Director/Board Member | - | 24/01 |
60 | - | ||
Director/Board Member | 62 | 24/01 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 126 572 749 | 81 786 701 ( 64,62 %) | 0 | 64,62 % |
Coordonnées société
Orchard Therapeutics Plc
245 Hammersmith Road 3rd Floor
W6 8PW, London
+44 20 3 808 8286
http://www.orchard-tx.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83 % | 653 Md | |
+27,00 % | 556 Md | |
-6,76 % | 354 Md | |
+20,34 % | 331 Md | |
+3,00 % | 296 Md | |
+13,09 % | 233 Md | |
+5,46 % | 201 Md | |
-9,61 % | 193 Md | |
-6,26 % | 144 Md |